HF
EVO icon

HRT Financial’s Evotec EVO Stock Holding History

HRT Financial’s Portfolio EVO Stock Details EVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26K Sell
10,510
-12,961
-55% -$41.8K ﹤0.01% 3540
2025
Q4 		$72K Buy
+23,471
New +$80.5K ﹤0.01% 2834

Other funds holding EVO

MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $375M AUM 72.65% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

HRT Financial's EVO Position: Q1 2026 in Review

HRT Financial reduced its Evotec (EVO) stake by 55% in Q1 2026, selling an estimated $41.8K and leaving 10,510 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #3540.

HRT Financial first reported a position in EVO in Q4 2025 and has held it in 2 quarters since. The position peaked at $72K in Q4 2025. 46 funds tracked by Wall St. Rank hold EVO as of Q1 2026.

  • HRT Financial held 10,510 shares of Evotec worth $26K as of Q1 2026.
  • HRT Financial sold 12,961 Evotec shares in Q1 2026, an estimated $41.8K.
  • Evotec made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3540 holding.
  • HRT Financial first reported a position in Evotec in Q4 2025 and has held it in 2 quarters since.
  • HRT Financial's Evotec position peaked at $72K in Q4 2025.
  • 46 funds tracked by Wall St. Rank held Evotec as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.